5,6-Dichlororibofuranosylbenzimidazole inhibits the rate of transcription initiation in intact Chironomus cells.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000546:Amanitins / Q000494:pharmacology; D000818:Animals; D002683:Chironomidae; D004004:Dichlororibofuranosylbenzimidazole / Q000494:pharmacology*; D007553:Isotope Labeling; D010761:Phosphorus Radioisotopes; D012332:RNA, Heterogeneous Nuclear / Q000378:metabolism*; D012263:Ribonucleosides / Q000494:pharmacology*; D014158:Transcription, Genetic / Q000187:drug effects*
D000546:Amanitins; D010761:Phosphorus Radioisotopes; D012332:RNA, Heterogeneous Nuclear; D012263:Ribonucleosides; D004004:Dichlororibofuranosylbenzimidazole; D000255:Adenosine Triphosphate